山东大学耳鼻喉眼学报 ›› 2024, Vol. 38 ›› Issue (3): 18-25.doi: 10.6040/j.issn.1673-3770.0.2022.219

• 论著 • 上一篇    下一篇

异常纺锤体样小头畸形相关蛋白在鼻咽癌中的表达及其临床意义

杨开炎1, 唐凤珠2, 覃启才1, 李旭祥3, 冯大益3, 农丰靖1, 杨秋云1   

  1. 1.百色市人民医院 耳鼻咽喉头颈外科, 广西 百色 533000;
    2.广西壮族自治区人民医院 耳鼻咽喉头颈外科, 广西 南宁 530000;
    3.百色市人民医院 病理科, 广西 百色 533000
  • 发布日期:2024-06-04
  • 通讯作者: 唐凤珠. E-mail:1960491231@qq.com

Expression of abnormal spindle-like microcephaly associated protein in nasopharyngeal carcinoma and its clinical significance

YANG Kaiyan1, TANG Fengzhu2, QIN Qicai1, LI Xuxiang3, FENG Dayi3, NONG Fengjing1, YANG Qiuyun1   

  1. 1. Department of Otorhinolaryngology & Head and Neck Surgery, People's Hospital of Baise, Baise 533000, Guangxi, China2. Department of Otorhinolaryngology & Head and Neck Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530000, Guangxi, China3. Department of Pathology, People's Hospital of Baise, Baise 533000, Guangxi, China
  • Published:2024-06-04

摘要: 目的 通过免疫组化染色的方法研究异常纺锤体样小头畸形相关蛋白(abnormal spindle-like microcephaly associated protein, ASPM)在鼻咽癌组织样本中的表达情况,进一步分析ASPM蛋白表达与鼻咽癌患者临床病理参数和预后的关系,探讨ASPM mRNA在鼻咽癌中的表达情况。 方法 从GEO数据库下载鼻咽癌的芯片数据集,使用R语言对鼻咽癌芯片数据集进行差异表达分析;使用免疫组化染色方法分析ASPM蛋白在鼻咽癌中的差异表达;使用卡方检验的方法分析ASPM表达与鼻咽癌患者临床病理参数的相关性;采用生存曲线分析ASPM表达与鼻咽癌患者预后的关系;采用Cox回归模型分析影响鼻咽癌患者预后的危险因素;使用受试者工作特征(receiver operator characteristic, ROC)曲线评估各种预后参数预测鼻咽癌患者预后的效能。 结果 通过鼻咽癌芯片数据分析发现ASPM mRNA在鼻咽癌芯片数据集中高表达(P<0.001);免疫组化染色结果显示鼻咽癌组织中ASPM蛋白表达明显高于鼻咽炎组织(P<0.001),ASPM表达与T分期(P=0.048)、N分期(P=0.050)及总临床分期(P=0.029)相关,高表达ASPM蛋白组患者总生存期短于低表达ASPM蛋白组患者(P<0.001);通过多因素Cox回归模型分析,显示ASPM表达水平可能为影响鼻咽癌患者预后的独立危险因素(P=0.015);通过ROC曲线分析,显示联合总临床分期及ASPM表达用于预测鼻咽癌患者预后具有更高的准确性(P<0.001)。 结论 ASPM在鼻咽癌组织样本中高表达,其高表达与鼻咽癌的恶性程度、疾病进展及较差的预后相关,可能成为鼻咽癌中有价值的预测预后的生物标志物。联合总临床分期及ASPM表达用于预测鼻咽癌患者预后可能是一种有前景的方法。

关键词: 鼻咽癌, 免疫组化, 肿瘤预后, 异常纺锤体样小头畸形相关蛋白, 差异表达

Abstract: Objective This paper investigated the expression of abnormal spindle-like microcephaly associated protein(ASPM)in nasopharyngeal carcinoma tissue samples using immunohistochemical staining, and further analyzed the relationship between ASPM protein expression and clinicopathological parameters and the prognosis of patients with nasopharyngeal carcinoma, and then discussed the expression of ASPM mRNA in nasopharyngeal carcinoma. Methods The microarray dataset of nasopharyngeal carcinoma was downloaded from the GEO database, and the differential expression of the nasopharyngeal carcinoma microarray dataset was analyzed using R language. The differential expression of ASPM protein in nasopharyngeal carcinoma was analyzed using immunohistochemical staining, the correlation between ASPM expression and clinicopathological parameters of patients with nasopharyngeal carcinoma was analyzed using the chi-square test, the relationship between ASPM expression and prognosis of patients with nasopharyngeal carcinoma was analyzed by survival curves, the risk factors affecting prognosis of patients with nasopharyngeal carcinoma were analyzed using the Cox regression model, and the receiver operator characteristic(ROC)curve was used to evaluate the performance of various prognostic parameters in predicting the prognosis of patients with nasopharyngeal carcinoma. Results ASPM mRNA was found to be highly expressed in nasopharyngeal carcinoma microarray data set through analysis of nasopharyngeal carcinoma microarray data(P<0.001). Immunohistochemical staining showed that expression of ASPM in nasopharyngeal carcinoma tissues was significantly higher than in nasopharyngitis tissues(P<0.001). ASPM expression correlated with T stage(P=0.048), N stage(P=0.050), and total clinical stage(P=0.029). The overall survival time of the high expression ASPM protein group was shorter than that of the low expression ASPM protein group(P<0.001). Multivariate Cox regression model analysis showed that ASPM expression level may be an independent risk factor affecting prognosis of patients with nasopharyngeal carcinoma(P=0.015). ROC curve analysis showed that total clinical stage combined with ASPM expression achieved a higher accuracy in predicting prognosis of patients with nasopharyngeal carcinoma(P<0.001). Conclusion ASPM is highly expressed in nasopharyngeal carcinoma tissue samples, and this high expression is related to malignancy, disease progression, and poor prognosis of nasopharyngeal carcinoma, and may become a valuable biomarker for predicting prognosis in nasopharyngeal carcinoma. Combining total clinical stage and ASPM expression may be a promising method for predicting prognosis of patients with nasopharyngeal carcinoma.

Key words: Nasopharyngeal carcinoma, Immunohistochemistry, Tumor prognosis, Abnormal spindle-like microcephaly associated protein, Differential expression

中图分类号: 

  • R766.3
[1] Wei WI, Sham JS. Nasopharyngeal carcinoma[J]. Lancet, 2005, 365(9476): 2041-2054. doi:10.1016/s0140-6736(05)66698-6
[2] 范黎, 黎越, 徐细明. 鼻咽癌同步放化疗前后炎性指标变化及预测价值[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 36-41. doi: 10.6040/j.issn.1673-3770.0.2020.053 FAN Li, LI Yue, XU Ximing. Changes in and prognostic value of the inflammatory index before and after concurrent chemoradiotherapy for nasopharyngeal carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 36-41. doi: 10.6040/j.issn.1673-3770.0.2020.053
[3] Wu CC, Fang CY, Hsu HY, et al. EBV reactivation as a target of luteolin to repress NPC tumorigenesis[J]. Oncotarget, 2016, 7(14): 18999-19017. doi:10.18632/oncotarget.7967
[4] Kouprina N, Pavlicek A, Collins NK, et al. The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein[J]. Hum Mol Genet, 2005, 14(15): 2155-2165. doi:10.1093/hmg/ddi220
[5] Zeng WJ, Cheng Q, Wen ZP, et al. Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas[J]. J Cell Mol Med, 2020, 24(17): 9613-9626. doi:10.1111/jcmm.15435
[6] 张锐, 沈雅芳, 安肖霞, 等. 人类异常纺锤体样小头畸形相关蛋白在非小细胞肺癌中的表达及其临床意义[J]. 中华危重症医学杂志(电子版), 2020, 13(3): 176-180. doi:10.3877/cma.j.issn.1674-6880.2020.03.004 ZHANG Rui, SHEN Yafang, AN Xiaoxia, et al. Expression of abnormal spindle-like microcephaly associated protein in non-small cell lung cancer and its clinical significance[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2020, 13(3): 176-180. doi:10.3877/cma.j.issn.1674-6880.2020.03.004
[7] Davis S, Meltzer PS. GEOquery: a bridge between the gene expression omnibus(GEO)and BioConductor[J]. Bioinformatics, 2007, 23(14): 1846-1847. doi:10.1093/bioinformatics/btm254
[8] Ritchie ME, Phipson B, Wu D, et al. Limma Powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res, 2015, 43(7): 47. doi:10.1093/nar/gkv007
[9] Liu YH, Li XN, Zhang YW, et al. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma[J]. Biomed Pharmacother, 2021, 143: 112096. doi:10.1016/j.biopha.2021.112096
[10] Adham M, Kurniawan AN, Muhtadi AI, et al. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation[J]. Chin J Cancer, 2012, 31(4): 185-196. doi:10.5732/cjc.011.10328
[11] Cabral de Carvalho Corrêa D, Dias Oliveira I, Mascaro Cordeiro B, et al. Abnormal spindle-like microcephaly-associated(ASPM)gene expression in posterior Fossa brain tumors of childhood and adolescence[J]. Childs Nerv Syst, 2021, 37(1): 137-145. doi:10.1007/s00381-020-04740-1
[12] Wang F, Li J, Liu J, et al. Controversial role of the possible oxyntic stem cell marker ASPM in gastric cancer[J]. J Pathol, 2017, 241(4): 559-561. doi:10.1002/path.4863
[13] Pai VC, Hsu CC, Chan TS, et al. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling[J]. Oncogene, 2019, 38(8): 1340-1353. doi:10.1038/s41388-018-0497-4
[14] Wu YG, You YJ, Chen L, et al. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer[J]. Gland Surg, 2022, 11(4): 687-701. doi:10.21037/gs-22-29
[15] 陈悦康, 王伟, 卢启海, 等. ASPM基因在肾透明细胞癌中的表达及其诊断预后的价值[J]. 临床泌尿外科杂志, 2020, 35(5): 398-402. doi:10.13201/j.issn.1001-1420.2020.05.015 CHEN Yuekang, WANG Wei, LU Qihai, et al. Expression and prognostic value of ASPM in renal clear cell carcinoma[J]. Journal of Clinical Urology, 2020, 35(5): 398-402. doi:10.13201/j.issn.1001-1420.2020.05.015
[16] 吕珊妹, 徐文杰, 王艺臻, 等. ASPM基因在乳腺癌中的表达及临床意义[J]. 医学研究杂志, 2020, 49(4): 93-99. doi:10.11969/j.issn.1673-548X.2020.04.020 LYU Shanmei, XU Wenjie, WANG Yizhen, et al. Expression of ASPM in breast cancer and its clinical significance[J]. Journal of Medical Research, 2020, 49(4): 93-99. doi:10.11969/j.issn.1673-548X.2020.04.020
[17] Feng ZX, Zhang J, Zheng YF, et al. Overexpression of abnormal spindle-like microcephaly-associated(ASPM)increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma[J]. Transl Cancer Res, 2021, 10(2): 983-997. doi:10.21037/tcr-20-2570
[18] 季家祥, 赵扬, 齐晓杰, 等. ASPM在肝癌中的表达及其与肝癌肝移植预后的关系[J]. 中华器官移植杂志, 2021, 42(7): 408-412. doi:10.3760/cma.j.cn421203-20200423-00132 JI Jiaxiang, ZHAO Yang, QI Xiaojie, et al. Expression of abnormal spindle-likemicrocephaly-associated in hepatocellular carcinoma and its prognostic relationship after liver transplantation for hepatocellular carcinoma[J]. Chinese Journal of Organ Transplantation, 2021, 42(7): 408-412. doi:10.3760/cma.j.cn421203-20200423-00132
[19] 王俊杰, 何振宇, 段仁慧. ASPM在肺腺癌中的表达及其与肺腺癌的进展和预后关系的研究[J]. 中国肺癌杂志, 2020, 23(1): 29-35. doi:10.3779/j.issn.1009-3419.2020.01.05 WANG Junjie, HE Zhenyu, DUAN Renhui. Expression of ASPM in lung adenocarcinoma and its relationship with development and prognosis[J]. Chinese Journal of Lung Cancer, 2020, 23(1): 29-35. doi:10.3779/j.issn.1009-3419.2020.01.05
[20] Gao ZY, Yu F, Jia HX, et al. ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer[J]. Kaohsiung J Med Sci, 2020, 36(12): 1021-1029. doi:10.1002/kjm2.12284
[21] Chan WL, Chow JCH, Xu ZY, et al. Management of nasopharyngeal carcinoma in elderly patients[J]. Front Oncol, 2022, 12: 810690. doi:10.3389/fonc.2022.810690
[22] Zeng Q, Xiang YQ, Wu PH, et al. A matched cohort study of standard chemo-radiotherapy versus radiotherapy alone in elderly nasopharyngeal carcinoma patients[J]. PLoS One, 2015, 10(3): 0119593. doi:10.1371/journal.pone.0119593
[23] Verma V, Surkar SM, Moreno AC, et al. Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer[J]. Cancer Med, 2018, 7(5): 1604-1611. doi:10.1002/cam4.1290
[24] Chiang CL, Guo QJ, Ng WT, et al. Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM staging by UICC: a systematic review of the literature[J]. Front Oncol, 2021, 11: 703995. doi:10.3389/fonc.2021.703995
[25] LI Jianpei, CHEN Shulin, PENG Songguo, et al. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics[J]. Int J Biol Sci, 2018, 14(5):549-556. doi: 10.7150/ijbs.24374
[26] Guo R, Mao YP, Tang LL, et al. The evolution of nasopharyngeal carcinoma staging[J]. Br J Radiol, 2019, 92(1102): 20190244. doi:10.1259/bjr.20190244
[1] 林小雪,林葆睿,李佩珊,卢标清. 电子鼻咽镜联合窄带成像技术在鼻咽癌中医辨证中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 40-46.
[2] 王盛,李银丹,杨金姬. microRNA在鼻咽癌中的作用及其研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 125-131.
[3] 邱前辉,肖旭平,杨钦泰,叶菁,邓泽义,王德生,谭国林,蒋卫红,卢永田,唐隽,石照辉,邓晓聪,刘遗斌,王跃武,段传志,杜德坤,白小欣,陈文伙,莫立根,蔡楚伟,曾鹏,何旭英,杨一梅,赵洲洋,陈健龙,赵充,林志雄,李先明,李曙平,陈冬平,陈勇,黄莹,陈春燕,韩非,黄理金,瞿申红. 鼻咽癌治疗后并发颈动脉爆裂综合征的临床处理专家共识[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 1-18.
[4] 王思权,朱洪申,张晓斌,赵洲洋,马跃,杨一梅,黄理金. 放射治疗后鼻咽癌患者单侧颈内动脉栓塞术后脑卒中及颅神经麻痹的相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 19-25.
[5] 黄巧,任毅,侯涛,廖行伟,朱子昂,詹晓琳,刘盈,尹时华. 鼻咽癌组织中EphB2表达及与临床病理特征的相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 26-30.
[6] 孙春晓,王文晴,岳田,刘济生. 高低累积顺铂剂量同步放化疗治疗鼻咽癌的疗效分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 31-41.
[7] 徐飞,朱光熹,王可心. 基于决策树算法构建鼻咽癌患者放疗后发生放射性口腔黏膜炎风险的预测模型[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 42-48.
[8] 王再兴,唐志元,李定波,石照辉,曾宪海,张秋航. 鼻咽癌放疗后肿瘤复发及颅底骨坏死引起颈内动脉破裂的治疗方案[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 49-58.
[9] 孙芳,谢楚波,邱前辉. 营养指标对鼻咽癌放射性颅底坏死患者创面修复影响的回顾性分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 59-68.
[10] 朱瑞楷,吴家荣,孙芳,谢楚波,邱前辉. 基于计算机断层扫描血管造影术评估鼻咽癌放疗后引起颈内动脉狭窄状况及其影响因素的研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 77-84.
[11] 覃德波,薛建成,杨文月,胡兵,陈涛,俞艳萍,孟庆国,孙焕吉,苗北平,卢永田. 鼻咽癌诊疗变革:生物标志物与鼻内镜手术协同推进早期治疗发展[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 85-92.
[12] 吴家荣,邱前辉. 颅底筋膜组织在早期复发性鼻咽癌内镜手术中的临床意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 108-113.
[13] 杨鸣,刘雪霞,张华. m6A识别蛋白IGF2BPs家族在头颈肿瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 153-161.
[14] 吴敏,李正阳,孟杰,叶惠平. 程序性细胞死亡的分子机制和其在鼻咽癌中的作用[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 152-157.
[15] 张茂华,魏日富,朱忠寿,刘平,高尚,李慧凤. LncRNA PCAT-1对鼻咽癌细胞生物学行为及化疗敏感性的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 68-76.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!